Utility of magnetic resonance imaging t2(*) in diagnosing and monitoring severe cardiac and hepatic siderosis.
S. Daar,Moez Hassan,V. Panjwani,A. Pathare,Humoud Al-Dhuhli,A. Al‐Riyami
2015-02-01
Sultan Qaboos University Medical Journal
Abstract:Patients with beta thalassaemia major (tm) require regular blood transfusions in order to survive; however, these transfusions are associated with a risk of iron overload. Toxic levels of iron accumulate mainly in the liver, heart and endocrine organs, causing multiple complications, and can only be removed by the regular use of iron chelating agents. Different modalities exist for monitoring body iron levels. Serum ferritin (SF) has been commonly used as it is widely available and has a low cost. However, SF is an acute-phase reactant and can be spuriously elevated in the presence of inflammation or infection. In addition, although serial measurements of SF are useful in monitoring patients with iron overload, they do not reflect organ-specific iron levels.
Historically, a liver biopsy for the assessment of hepatic iron (in mg per g of dry weight [mg/gdw]) has been the gold standard.1 A liver iron concentration (LIC) of >15 mg/gdw indicates severe iron overload and is associated with increased morbidity and mortality.2 However, it is invasive and does not accurately reflect hepatic iron content in the presence of heterogeneous iron distribution. The current state-of-the-art methods for measuring organ iron overload are magnetic resonance imaging (MRI) techniques. Although R2 MRI is a robust technique for measuring hepatic iron content, MRI T2* is more widely available and can assess both hepatic and cardiac iron.3,4 The latter is particularly important as in many cases neither SF nor LIC correlates well with cardiac iron content.4 For instance, a patient can have a relatively low SF level and LIC but still have dangerously high levels of myocardial iron. Anderson et al. showed that a cardiac MRI T2* of 10 ms.5 Using MRI techniques, it is possible to evaluate iron overload in different organs in a noninvasive manner as well as safely monitor the effects of chelation therapy.
MRI T2* imaging has been used at the Sultan Qaboos University Hospital (SQUH) in Muscat, Oman, as part of the regular management of TM patients since 2006. MRIs are performed using the 1.5T Siemens Sonata scanner (Siemens Healthcare Corp., Malvern, Pennsylvania, USA) according to protocols described by Anderson et al. and Westwood et al.4,6 T2* values were calculated using software from CMRtools (Cardiovascular Imaging Solutions Ltd., London, UK). Hepatic iron (LIC) was calculated from liver MRI T2* scans as described by Wood et al.7